AbbVie's Entenamig Shows Promising Results for Relapsed/Refractory Multiple Myeloma in Phase 3 CERVINO Trial #United_States #AbbVie #North_Chicago #Entenamig #CERVINO
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialAbbVie's Entenamig Shows Promising Results for Relapsed/Refractory Multiple Myeloma in Phase 3 CERVINO Trial #United_States #AbbVie #North_Chicago #Entenamig #CERVINO